Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept. uri icon

authors

  • Suzann Pershing, MD, MS
  • Talwar, Nidhi
  • Armenti, Stephen T
  • Grubbs, Joseph
  • Rosenthal, Julie M
  • Dedania, Vaidehi S
  • Stein, Joshua D

publication date

  • January 1, 2019